Explorer les evidences

8,29 mlThe mean testicular volume among HIV-infected boys was 8.29 ± 8.26 ml, compared to 11.57 ± 8.26 ml in uninfected controls.

NigeriaVIH/sidapublié 2022The Pan African medical journalPubMeddocument de 3 observations

83,6 %Of 2,180 children seen at all facility points of service with unknown HIV status, 1,822 (83.6%) were tested for HIV.

NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 16 observations

9,2 %9.2% of HIV genotyped specimens showed high-level resistance to efavirenz and nevirapine.

NigeriaVIH/sidaobservé 2020publié 2026Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 5 observations

21,9 %Non-adherence accounted for 21.9% (n=47) of the 215 drug therapy problems identified among PLWH in the study.

NigeriaVIH/sidapublié 2021The Pan African medical journalPubMeddocument de 11 observations

62 %Among 563 patients in a Nigerian cohort of people with HIV newly initiating antiretroviral therapy, 62% were female.

NigeriaVIH/sidapublié 2023International journal of behavioral medicinePubMeddocument de 7 observations

0,125 per_1One out of every eight patients living with HIV infection may likely have Eustachian tube dysfunction.

NigeriaVIH/sidapublié 2023Nigerian journal of clinical practicePubMeddocument de 6 observations

349 participantsA total of 349 youth living with HIV enrolled in the study.

NigeriaVIH/sidapublié 2020Journal of medical Internet researchPubMeddocument de 5 observations

417 individualsThe study analyzed HIV-1 pol sequences from 417 MSM living with HIV enrolled in the TRUST/RV368 cohort between 2013 and 2017 in Abuja and Lagos, Nigeria.

NigeriaVIH/sidaobservé 2013 to 2017publié 2020AIDS (London, England)PubMeddocument de 2 observations

Low serum HDL-c was the most prevalent form of dyslipidaemia in all three groups studied.

NigeriaVIH/sidapublié 2022African health sciencesPubMeddocument de 6 observations

37 %The prevalence of microalbuminuria (urine/albumin creatinine ratio 30–300 mg/g) was 37% among HIV-positive Nigerian adults.

NigeriaVIH/sidapublié 2021Kidney internationalPubMeddocument de 7 observations

35,9 adjusted_odds_ratioAdvanced HIV disease was an independent risk factor for severe mpox disease (adjusted odds ratio 35.9, 95% CI 4.1–252.9).

Nigeriampox · VIH/sidapublié 2023The Lancet. Infectious diseasesPubMeddocument de 11 observations

90 %90% of participants have good knowledge of premarital screening for HIV/AIDS.

NigeriaVIH/sidapublié 2023West African journal of medicinePubMeddocument de 4 observations

63 %Among those linked to treatment, retention was 63% in the one-stop-shop (OSS) model and 48% in the hybrid HIV prevention and treatment site (DIC) model.

NigeriaVIH/sidapublié 2025BMC public healthPubMeddocument de 8 observations

4,2 %Among 265 livestock handlers in Ibadan, Nigeria, 11 (4.2%) tested positive for HIV infection.

NigeriaVIH/sidaobservé October 2016 to April 2017publié 2024African health sciencesPubMeddocument de 5 observations

48 %Compared to pre-fee patients, the post-fee period had a 48% decreased risk of care interruption (aRR = 0.52, 95%CI:0.39–0.69).

NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 9 observations

70 %Sub-Saharan Africa accounted for 70% of the global number of people living with HIV in 2018.

NigeriaVIH/sidaobservé 2018publié 2022The Journal of the Association of Nurses in AIDS Care : JANACPubMeddocument de 6 observations

0,26 hazard_ratioParticipants with viral loads less than 1000 copies/ml had a hazard ratio of 0.26 for death compared to those with higher viral loads.

NigeriaVIH/sidapublié 2025PloS onePubMeddocument de 8 observations

1 casesOne (4.5%) high risk infant had HIV DNA PCR testing between 6–8 weeks.

NigeriaVIH/sidapublié 2025West African journal of medicinePubMeddocument de 8 observations

2,1 aORLiving with HIV for over 6 years was independently associated with a two-fold increased knowledge about HPV's carcinogenicity (adjusted odds ratio: 2.1, 95% confidence interval: 1.1–4.1).

Nigeriainfection à HPV · VIH/sidapublié 2025Sexual healthPubMeddocument de 9 observations

74 %Anemia prevalence was 74% among HIV-infected subjects.

Nigeriaanémie · VIH/sidapublié 2019BMC infectious diseasesPubMeddocument de 7 observations

46,4 %HIV serodiscordance rates were 46.4% among expert mothers versus 55.6% among non-expert mothers.

NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 7 observations

505 000 000 USDAt current coverage rates, the annual treatment costs for adults living with HIV in Nigeria would range between US$ 505 million in 2020 to US$ 655 million in 2025.

NigeriaVIH/sidaobservé 2020 to 2025publié 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 5 observations

2 %HIV infection was found in 1-3% of patients with probable malaria at different sites in Lagos, Nigeria.

Nigeriapaludisme · VIH/sidapublié 2022BMC research notesPubMeddocument de 3 observations

Antiretroviral therapy enables persons with HIV to live longer.

NigeriaVIH/sidapublié 2024The American journal of tropical medicine and hygienePubMeddocument de 6 observations

31,25 %In envelope (env) gp120, 31.25% of the HIV-1 samples reacted to a CRF02 (subtype A) probe.

NigeriaVIH/sidapublié 2016MedicinePubMeddocument de 7 observations